
Trump Administration Executive Order (EO) Tracker
The French Finance Act for 2025 radically overhauled the tax and social security treatment of management packages.
The BSPCE regime is also subject to some amendments.
Key changes and features you need to be aware of:
The French Finance Act for 2025 radically overhauled the tax and social security treatment of management packages. Coming into force on February 15, 2025, this legislation, codified under Article 163 bis H of the French tax code, aims to resolve the uncertainties that have concerned private equity and venture capital professionals following the French Supreme Administrative Court’s rulings on July 13, 2021.
This new provision establishes the principle pursuant to which "the net gain realized on securities subscribed or acquired by employees or managers, or granted to them, is taxed according to the general salary rules when it is acquired in consideration for the duties of an employee or manager in the company issuing the securities". By way of exception, and subject to certain criteria, the gain, up to a determined cap, may benefit from the tax and social security regime applicable to capital gains (the "Capital Gains Regime"), i.e., a flat tax of 34%1.
In principle, this regime applies to all employee shareholding schemes, whether governed by legal provisions (free shares, BSPCE, stock options) or not (ratchet shares, stock warrants, etc.). The French Finance Act for 2025 has legalized the prohibition of registering securities covered by this regime in a PEA / PEA-PME.
However, the application of this regime to a given individual will have to be analyzed on a case-by-case basis, depending on the type of instrument and the situation specific to each holder.
For instruments governed by a so-called legal regime, the eligibility for the Capital Gains Regime now requires a risk of loss of the acquisition or subscription cost to be supported by the employee / manager. For unregulated instruments, a risk of capital loss must also exist, together with a minimum two-year holding period.
The main feature of this regime is that the Capital Gains Regime applies up to a specific cap determined by a financial performance multiple, which, in practice, should correspond to the project multiple.
The project multiple is defined as three times the ratio between (i) the company’s fair market value at the time of sale and (ii) the fair market value recorded when the shares were acquired or allocated, as such
With :
In the case where securities are held through a “ManCo” or similar entity, a look-through approach must be applied, meaning the operational company’s fair market value will replace that of the “ManCo”.
The net sale is then taxed as follows:
It should be noted that if the above eligibility conditions are not met, the entire gain will be taxed as salary income and be subject to the 10% employee specific contribution.
In addition, the portion of the gain taxed as salary income would remain taxable in the event of a roll-over, as no tax deferral or tax suspension would apply. In practice, this should have an impact on the quantum of reinvestment by employees/managers in LBO or venture capital transactions, as the tax will become due and payable upon reinvestment, even though no cash proceeds would have been realized from a sale.
Furthermore, in the event where prior to a transaction, an employee/manager proceeds with a donation of a portion of the shares held in a target company followed by a sale, the entire gain would remain taxable at the level of the donor upon the sale of the securities by the beneficiary. These tax impacts have given rise to controversy and a harsh lobbying from advisors and manager representatives. The French Tax Authorities’ administrative guidelines in this respect are eagerly awaited, practitioners are hoping for clarifications and potential adjustments.
As far as employers and sponsors are concerned, the entire gain recognized upon the sale of the shares is exempt from employer social security contributions. This is a key advantage, as it effectively eliminates the risk of application of French social security contributions to the instruments falling under this new regime.
Since the new regime requires a link between the acquisition or subscription of the instruments and employee or executive functions, it should allow for the a wider use of vesting mechanisms, good/bad leaver clauses, and references to non-compete clauses outside of the employment contract or social mandate, without necessarily negatively impacting the tax treatment of the management package.
Key uncertainties that still need to be clarified:
Although this legislation provides greater clarity in a previously uncertain tax and social environment, there are still several grey areas that need to be clarified by the French tax authorities in order to comfort venture capital and private equity professionals. It is also regrettable that this text has not been debated before the Parliament during the legislative process.
With regard to BSPCE, the new Article 163 bis G of the French tax code, resulting from the French Finance Act for 2025, now distinguishes between (i) the exercise gain and (ii) the net sale gain from securities subscribed to after exercising the BSPCE. These provisions apply to securities subscribed from January 1, 2025, regardless of the date when the BSPCE were granted.
In addition, BSPCE and securities subscribed to after exercising the of BSPCE may no longer be registered under a PEA / PEA-PME. This measure applies retroactively from October 10, 2024. For securities already registered under a PEA / PEA-PME prior to this date, the holder may withdraw them without consequence, provided certain conditions are met.
Note: in practice, the impact of this reform should be limited for BSPCE, as they are usually exercised as part of a liquidity event, thus limiting the carry of the securities. As the gain on disposal is nil, the new regime should not impact the tax treatment of the gain.
With regards to stock options, the taxation of the gain on exercise of the option remains unchanged and is taxed based on the marginal income rate up to 49%5 as well as social security levies at a rate of 9.7%, plus a specific employee contribution of 10%. The capital gain realized upon disposal of the stock options is, in principle, taxable based on the capital gains regime, but will now fall within the scope of the new regime and its financial performance cap.
With regards to free share, taxation of the acquisition gain remains unchanged, i.e., up to a limit of €300,000 it is taxed based on the marginal income tax rate up to 49% after a 50% allowance is applied as well as social security levies at a rate of 17.2%. The portion of the gain exceeding €300,000 is taxed based on the marginal income tax rate up to 49%6 as well as social security levies at a rate of 9.7%, plus a specific employee contribution of 10%. The gain realized upon the disposal of the free shares is, in principle, taxable based on the capital gains regime, but will now also fall within the scope of the new regime and its financial performance cap.
Authored by Ludovic Geneston, Xenia Legendre, and Alexis Caminel.
We would be pleased to further discuss with you the impact of this new regime on existing management packages and the structuring of future ones.
Although not covered by the law, in the case of BSPCE and stock options, the grant date of the instruments should be taken into account.
Including the exceptional contribution on high revenue up to 4%.
Including the exceptional contribution on high revenue.
Including the exception contribution on high revenue.